Log in to save to my catalogue

Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel tre...

Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel tre...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2617278304

Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis

About this item

Full title

Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Cancer chemotherapy and pharmacology, 2022-02, Vol.89 (2), p.173-181

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Large interindividual variability in the pharmacokinetic properties of docetaxel has been reported, with the clearance of docetaxel varying nearly six fold, in which pharmacogenetics of docetaxel may play an essential role in addition to physiological factors. The association between the gene polymorphism and risk of adverse clinical eff...

Alternative Titles

Full title

Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2617278304

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2617278304

Other Identifiers

ISSN

0344-5704

E-ISSN

1432-0843

DOI

10.1007/s00280-021-04374-3

How to access this item